These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23192520)

  • 21. Cystatin C is differentially involved in multiple system atrophy phenotypes.
    Urbizu A; Canet-Pons J; Munoz-Marmol AM; Aldecoa I; Lopez MT; Compta Y; Alvarez R; Ispierto L; Tolosa E; Ariza A; Beyer K
    Neuropathol Appl Neurobiol; 2015 Jun; 41(4):507-19. PubMed ID: 24606172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival in synucleinopathies: A prospective cohort study.
    Goldstein DS; Holmes C; Sharabi Y; Wu T
    Neurology; 2015 Nov; 85(18):1554-61. PubMed ID: 26432848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definite familial multiple system atrophy with unknown genetics.
    Itoh K; Kasai T; Tsuji Y; Saito K; Mizuta I; Harada Y; Sudoh S; Mizuno T; Nakagawa M; Fushiki S
    Neuropathology; 2014 Jun; 34(3):309-13. PubMed ID: 24397755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy.
    Tada M; Onodera O; Tada M; Ozawa T; Piao YS; Kakita A; Takahashi H; Nishizawa M
    Arch Neurol; 2007 Feb; 64(2):256-60. PubMed ID: 17296842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of Multiple System Atrophy in Hokkaido, the Northernmost Island of Japan.
    Sakushima K; Nishimoto N; Nojima M; Matsushima M; Yabe I; Sato N; Mori M; Sasaki H
    Cerebellum; 2015 Dec; 14(6):682-7. PubMed ID: 25910615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and autonomic testing predict survival in multiple system atrophy.
    Coon EA; Sletten DM; Suarez MD; Mandrekar JN; Ahlskog JE; Bower JH; Matsumoto JY; Silber MH; Benarroch EE; Fealey RD; Sandroni P; Low PA; Singer W
    Brain; 2015 Dec; 138(Pt 12):3623-31. PubMed ID: 26369944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple system atrophy of the cerebellar type: clinical state of the art.
    Lin DJ; Hermann KL; Schmahmann JD
    Mov Disord; 2014 Mar; 29(3):294-304. PubMed ID: 24615754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.
    Roncevic D; Palma JA; Martinez J; Goulding N; Norcliffe-Kaufmann L; Kaufmann H
    J Neural Transm (Vienna); 2014 May; 121(5):507-12. PubMed ID: 24337696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnostic relevance of high resolution magnetic resonance in patients with possible multiple system atrophy (MSA) - A case report.
    Baronica KB; Ivkić G; Ozretić D; Milicević G
    Coll Antropol; 2011 Jan; 35 Suppl 1():287-92. PubMed ID: 21648349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple system atrophy: prognostic factors in the "MSA-Aquitaine" cohort].
    Krim E; Yekhlef F; Chrysostome V; Ghorayeb I; Tison F
    Rev Neurol (Paris); 2007 Jan; 163(1):54-65. PubMed ID: 17304173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First symptoms in multiple system atrophy.
    McKay JH; Cheshire WP
    Clin Auton Res; 2018 Apr; 28(2):215-221. PubMed ID: 29313153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Preclinical" MSA in definite Creutzfeldt-Jakob disease.
    Rodriguez-Diehl R; Rey MJ; Gironell A; Martinez-Saez E; Ferrer I; Sánchez-Valle R; Jagüe J; Nos C; Gelpi E
    Neuropathology; 2012 Apr; 32(2):158-63. PubMed ID: 21692862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
    Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
    Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study.
    Compta Y; Dias SP; Giraldo DM; Pérez-Soriano A; Muñoz E; Saura J; Fernández M; Bravo P; Cámara A; Pulido-Salgado M; Painous C; Ríos J; Martí MJ;
    Parkinsonism Relat Disord; 2019 Aug; 65():3-12. PubMed ID: 31178335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death.
    Tada M; Kakita A; Toyoshima Y; Onodera O; Ozawa T; Morita T; Nishizawa M; Takahashi H
    Brain; 2009 Jul; 132(Pt 7):1810-9. PubMed ID: 19429902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex families with multiple system atrophy.
    Hara K; Momose Y; Tokiguchi S; Shimohata M; Terajima K; Onodera O; Kakita A; Yamada M; Takahashi H; Hirasawa M; Mizuno Y; Ogata K; Goto J; Kanazawa I; Nishizawa M; Tsuji S
    Arch Neurol; 2007 Apr; 64(4):545-51. PubMed ID: 17420317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course.
    Masui K; Nakata Y; Fujii N; Iwaki T
    Neuropathology; 2012 Feb; 32(1):69-76. PubMed ID: 21615514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
    Vanacore N; Bonifati V; Fabbrini G; Colosimo C; De Michele G; Marconi R; Nicholl D; Locuratolo N; Talarico G; Romano S; Stocchi F; Bonuccelli U; De Mari M; Vieregge P; Meco G;
    Neurol Sci; 2001 Feb; 22(1):97-9. PubMed ID: 11487219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.